Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 9)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 9)

Results 161 - 180 of 983 in Lipitor, Atorvastatin (generic)

  1. Alternative medicine: There should only be one standardRead the original story w/Photo

    Sep 16, 2014 | Kevin, M.D.

    "Doctor, what do you think of alternative medicine?" a patient with chronic fatigue syndrome asked me the other day. She was interested in doing something more for her severe fatigue.

    Comment?

  2. Older Patients More Likely to Fill Prescriptions for Generic StatinsRead the original story w/Photo

    Sep 15, 2014 | MedlinePlus

    Patients prescribed cholesterol-lowering drugs are more likely to fill their prescriptions and gain health benefits if the medications are cheaper generic brands, new research suggests. At issue are the cholesterol-lowering drugs known as statins.

    Comment?

  3. Patients Taking Generic Statins More Likely To Stick To Their Drug Regimen, Benefiting Their HeartsRead the original story w/Photo

    Sep 15, 2014 | Medical Daily

    Though both brand name and generic statins are equally effective in the way they work, a new study finds that people who take generics may end up living longer. When choosing whether to go with a generic store-brand version of a drug, such as ibuprofen, or its more expensive brand name version , chances are that most of us will choose the generic version on the basis that they all have the same chemical composition, and are thus equally effective.

    Comment?

  4. Feeling ripped off againRead the original story

    Sep 14, 2014 | Journal-Pioneer

    Editor, The Ghiz government has done it again. Remember those "housekeeping" bills that were slipped through at the close of the fall 2013 session of legislature? Well, some of them are not quite as innocuous as we were led to believe.

    Comment?

  5. A promising new approach to Alzheimer'sRead the original story

    Sep 14, 2014 | McGill News

    The quest to find a cure for Alzheimer's disease, which affects about 750,000 Canadians, has been maddeningly difficult. Most approaches have focused on identifying the genetic and environmental risk factors responsible for causing or accelerating the progression of this devastating condition.

    Comment?

  6. Cholesterol Drugs' Benefits Far Outweigh Side Effects, Review FindsRead the original story w/Photo

    Aug 5, 2014 | Philly.com

    The benefits of long-term use of cholesterol-lowering statin drugs greatly outweigh the risks, according to a review of research published over 20 years. Some experts fear that statins may be overused, but these new findings could offer reassurance to the more than 200 million people worldwide who take the drugs, the review authors said.

    Comment?

  7. How Pharmaceutical Products Differ From Tennis BallsRead the original story w/Photo

    Sep 13, 2014 | OpEdNews

    In addition to the fact that it is too big to swallow, there are a number of critical ways in which a tennis ball, viewed as a commercial product, is very different from any medication that one might buy in a drugstore. The differences are very important, and illuminate the pressing need to treat the manufacture and sale of pharmaceutical products very differently.

    Comment?

  8. Biotech Drug Copies May Save U.S. $250 Billion as Safety DebatedRead the original story

    Sep 12, 2014 | The Washington Post

    At least 14 expensive biotechnology medicines that have never before faced generic rivals in the U.S. are being targeted by drugmakers who want to sell imitations at cheaper prices, according to regulators. For years, patients have been able to buy less expensive copies of existing chemical drugs -- ranging from Lipitor for cholesterol to the antidepressant Prozac -- once their patents ended.

    Comment?

  9. Biotech Drug Savings of $250 Billion Close to Reaching U.S.Read the original story

    Sep 12, 2014 | The Washington Post

    At least 14 expensive biotechnology medicines that have never before faced generic rivals in the U.S. are being targeted by drugmakers who want to sell imitations at cheaper prices, according to regulators. For years, patients have been able to buy less expensive copies of existing chemical drugs -- ranging from Lipitor for cholesterol to the antidepressant Prozac -- once their patents ended.

    Comment?

  10. Why I'd Avoid Pfizer Inc. Stock Despite the DividendRead the original story

    Sep 11, 2014 | The Motley Fool

    Dividend stocks tend to be strong performers over the long term due to their ability to harness the awesome power of compounding returns. Even so, investors should always bear in mind that not all dividend stocks are good investments, even when they are associated with a strong brand.

    Comment?

  11. Losing Your Memory: It May be the Drugs You're TakingRead the original story w/Photo

    Sep 10, 2014 | Psychology Today

    Is memory loss interfering with your daily life? Most people are familiar with some of the things that can impair memory, including alcohol and drug abuse, head injuries, stroke, sleep deprivation, severe stress , aging or a symptom of conditions like Alzheimer's disease. What many do not know is that episodes of forgetfulness can also be side effects of prescription drugs.

    Comment?

  12. Ways to Spend Less on Prescription DrugsRead the original story w/Photo

    Aug 21, 2014 | Kiplinger Online

    As health insurers shift more of the cost burden to consumers, the average U.S. worker with employer-provided coverage now pays $9,695 per year in premiums and out-of-pocket costs for a family of four - a 118% increase over the past decade, according to the Milliman Medical Index. If you buy coverage on your own, you may be spending even more.

    Comment?

  13. Study indicates that statins may protect against microvascular complications of diabetesRead the original story w/Photo

    Sep 10, 2014 | PhysOrg Weblog

    The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology . It is well established that statins via cholesterol lowering effectively reduce the risks of heart attack and stroke in people with type 2 diabetes, but whether statin use affects the development of small blood vessel complications, such as eye, nerve, and kidney disease in individuals with diabetes is not known.

    Comment?

  14. Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial...Read the original story

    Sep 7, 2014 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Despite appropriate anti-malarial treatment, cerebral malaria -associated mortalities remain as high as 30%.

    Comment?

  15. US Acute Coronary Syndrome Drugs Industry (Antithrombotics,...Read the original story

    Sep 7, 2014 | Sys-Con Media

    MarketOptimizer.org adds "Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023", a new research report to its store. Overview of ACS, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

    Comment?

  16. Use of ivabradine and atorvastatin in emergent orthopedic lower limb...Read the original story

    Sep 6, 2014 | Trials Journal

    The incidence of perioperative myocardial infarction globally is known to be around 2 to 3% and can prolong hospitalization, increased morbidity and mortality. Little is known about the pathophysiology and risk factors for PMI.

    Comment?

  17. Researchers to study effectiveness of atorvastatin in preventing...Read the original story w/Photo

    Sep 5, 2014 | Medical News

    Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer. The National Heart, Lung and Blood Institute awarded Wake Forest Baptist $3 million for the project and the National Cancer Institute contributed $1.4 million.

    Comment?

  18. Pittsburgh coalition told unity will rein in health care costsRead the original story w/Photo

    Sep 4, 2014 | Pittsburgh Post-Gazette

    The "C-suite" executives - the chief executive officer, the chief financial officer and every other chief - must band together if they are to overcome the power of the health care industry and rein in health care costs. That was the message Thursday from Brian Klepper, CEO of the National Business Coalition on Health, who was the keynote speaker for Pittsburgh Business Group on Health's annual symposium at the Downtown Marriott.

    Comment?

  19. Researchers Receive $4.4 Million in Federal Funds to Determine If...Read the original story

    Sep 4, 2014 | Newswise

    Sept. 4, 2014 - Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer. The National Heart, Lung and Blood Institute awarded Wake Forest Baptist $3 million for the project and the National Cancer Institute contributed $1.4 million.

    Comment?

  20. Is It Time to Buy Pfizer Inc.'s Stock?Read the original story w/Photo

    Sep 2, 2014 | The Motley Fool

    A combination of high-branded drug margins coupled with the expectation that the Affordable Care Act, better known as Obamacare, will translate into a long-term positive for the company have pushed its stock back near the $30 per share mark.

    Comment?